Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Perceived empowerment and the impact of negative effects of the COVID-19 pandemic on the quality of life of persons with severe mental illness

  • Annabel Sandra Mueller-Stierlin ,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    annabel.mueller-stierlin@uni-ulm.de

    Affiliations Department of Psychiatry II, Ulm University, Günzburg, Germany, Department of General Practice and Primary Care, Ulm University, Ulm, Germany

    ⨯
  • Friedrich Meixner,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Jutta Lehle,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Anne Kohlmann,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Mara Schumacher,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Stefanie Woehler,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Anke Haensel,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Sabrina Reuter,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Katrin Herder,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Nicole Bias,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯
  • Thomas Becker,

    Roles Conceptualization, Funding acquisition, Writing – review & editing

    Affiliation Department of Psychiatry, University of Leipzig, Leipzig, Germany

    ⨯
  • Reinhold Kilian

    Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Department of Psychiatry II, Ulm University, Günzburg, Germany

    ⨯

Abstract

Purpose

Beyond its direct effects on physical health the COVID-19 pandemic has been shown to have negative effects on the living situation of people with severe mental illness (SMI). To date, there has been little research on resilience factors preventing people with SMI from experiencing negative effects of the COVID-19 pandemic.

The objective of this study was to investigate the role of perceived empowerment (PE) as a resilience factor, preventing people with SMI from experiencing negative effects of the COVID-19 pandemic on daily living.

Methods

We investigated negative effects of the COVID-19 pandemic on daily living in 931 persons with SMI at two times within six month between June 2020 and Mai 2021. To take into account the longitudinal structure of the data we applied mixed effects regression analyses and longitudinal path models.

Results

A majority of participants experienced negative effects of the COVID-19 pandemic on several dimensions of daily living. Negative effects increased with rising levels of illness-related impairment but decreased as the level of PE rose. While negative effects of the COVID-19 pandemic at follow-up were negatively associated with overall subjective quality of life baseline, PE was negatively associated with the negative impact of the pandemic and positively with quality of life.

Conclusion

Patients with SMI need support to reduce negative effects of the COVID-19 pandemic on their quality of life. The promotion of PE could help strengthen resilience in this target group.

Trial registration

German Clinical Trial Register, DRKS00019086, registered on 3 January 2020. (https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00019086).

Citation: Mueller-Stierlin AS, Meixner F, Lehle J, Kohlmann A, Schumacher M, Woehler S, et al. (2022) Perceived empowerment and the impact of negative effects of the COVID-19 pandemic on the quality of life of persons with severe mental illness. PLoS ONE 17(10): e0276123. https://doi.org/10.1371/journal.pone.0276123

Editor: Dylan A. Mordaunt, Flinders University, AUSTRALIA

Received: August 3, 2022; Accepted: September 27, 2022; Published: October 20, 2022

Copyright: © 2022 Mueller-Stierlin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: The individual pseudonymized data, as used for the analysis, would allow some institutions (e.g. health insurance providers and service providers involved in the project) to identify the respective participants based on their routine documentation. Though, the datasets generated during and analysed during the current study are available from the Department of Psychiatry II, Ulm University (psychiatrie@bkh-guenzburg.de) on reasonable request. The project acronym “GBV” should be indicated along the request.

Funding: This study and most authors (AMS, FM, JL, AK, MS, SW, AH, SR, KH, and NB) are funded by the Innovation Fund from the Federal Joint Committee (G-BA, https://innovationsfonds.g-ba.de/), grant number 01NVF18028 (GBV). The funder was not involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

The COVID-19 pandemic has significantly affected the quality of life of citizens all over the world. Even those who were not infected by the SARS CoV-II virus had to cope with the restrictions on personal freedom and public life [1,2]. The psychological impact of the COVID-19 pandemic has been investigated in a large number of studies worldwide and recent reviews of this research has come to the conclusion that in many countries after an initial increase in symptoms of psychological distress, people in the general population seemed to have mentally adapted to the challenges of daily life related to the COVID-19 pandemic after the first months [3–9]. Nevertheless, several studies have identified population groups which are at higher risk of becoming more severely and more durably affected [1,6,10–12] as well as social, economic and individual characteristics which make people in general more resilient against the adverse psychological effects of the pandemic [13,14].

Among other vulnerable groups, persons with severe mental illness (SMI) have been expected by many experts to become particularly affected by the psychological distress caused by fear of infection, increasing social isolation, and restricted access to mental health care services [15–27]. However, most of the studies on the impact the COVID-19 pandemic on psychopathological symptoms suggested that the majority of patients with mental illness seemed to have adapted to the challenges of the pandemic after the first wave as well as people without pre-existing mental health problems [6,16,17,28–39]. Nevertheless, these results do not indicate that the pandemic had no impact on the quality of life and the well-being of people with mental disorder at all. On the contrary, several studies indicated that whilst the number of general psychiatric inpatient admissions as well as the number of psychiatric outpatient contacts decreased significantly [11,26,32,40–45] at least some facilities reported increases of involuntary and emergency admissions due to mental disorder [24,40,41,45–48]. Overall, results are mixed; most studies provide a contradictory picture indicating not only negative effects or none whatsoever, but even positive effects of the pandemic depending on clinical and sociodemographic characteristics of the investigated target groups [12,28,31,33,39,46,48–50].

In order to develop and implement strategies to identify and support those patient groups with an increased risk of becoming negatively affected by restrictions and other challenges related to the COVID-19 pandemic, a stronger focus of research on potential resilience factors is needed [13]. Concerning other psychological and social characteristics, perceived empowerment (PE) has been identified a key resource enabling people with SMI to manage disease related adversities in the process of recovery [51–57]. PE is defined as the perception of control and mastery over one’s life, and of the perceived ability to utilize one’s skills to prevent or cope with life events [58–60]. PE is regarded as a crucial factor in resilience theory [60] suggesting that PE improves an individual’s capacity to cope with health related environmental challenges in a way that decreases potential negative effects on well-being and quality of life [61,62]. Only recently the improvement of PE by means of an online training program has been considered as a resource helping vulnerable population groups to cope with the challenges caused by the COVID-19 pandemic [62]. However, although the important role of PE in the process of recovery from mental disorder has been widely demonstrated, to date there is no research about the potential effects of PE as a resource that could help people with SMI to cope with the psychosocial adversities of the COVID-19 pandemic.

Objectives

In this investigation we want to answer the following research questions:

How do patients with SMI perceive the COVID-19 pandemic having negative effects on different dimensions of their life?

How is the experience of negative COVID-19 effects associated with socioeconomic and clinical characteristics?

To what extent is change of the experience of negative effects of the COVID-19 pandemic moderated by PE and by functional impairment due to mental illness?

How is the experience of negative effects of the COVID-19 pandemic associated with the patients’ subjective quality of life?

Methods

Design and sample

The data of this investigation were collected as part of a multi-site randomized controlled trial (RCT) for the evaluation of an intervention providing a community psychiatric service intervention (GBV) for people with SMI in addition to care as usual (CAU). Details of the study have been published in the study protocol [63]. This study was approved by the Ethics Committee of Ulm University on August 28, 2019 (application number: 259/19), and by local ethics committees (Landesärztekammer Bayern, Landesärztekammer des Saarlandes, Landesärztekammer Berlin, Landesärztekammer Sachsen, Landesärztekammer Nordrhein, Landesärztekammer Westfalen-Lippe). While the original RCT includes four follow-up assessments after baseline, only baseline and first follow-up data are used in this investigation.

Due to the COVID-19 pandemic the study onset had been postponed for 6 months from January 2020 to June 2020. In addition, the originally planned face-to-face assessment was changed to an internet based video interview with an online data collection. Only in cases where participants refused video interviewing or had not the technical requirements necessary for video interviewing, the assessment was conducted face-to-face.

Study participants were recruited at 12 locations across Germany [63]. Potential study participants were first contacted by local mental health service providers or by health insurances if they had a psychiatric diagnosis and received psychiatric treatment during the last year. After signing an informed consent all participants were screened for fulfilling the criteria of a SMI by means of a standardized screening procedure [63]. If they fulfilled the SMI criteria, participants were randomized either to GBV or to CAU and the baseline assessment was performed by a research worker.

Assessment instruments

The “Health of the Nations Outcome Scale” (HoNOS) is an expert rating instrument to assess the impairment due to mental disorder on twelve dimensions including, agitated or aggressive behavior, depression, hallucination, self-impairment, substance abuse, cognitive capability, social relationships, daily living, accommodation, occupation and physical health [64–66]. For this investigation the HoNOS total score was used.

The “Empowerment in Patients with Affective and Schizophrenia disorders scale” (EPAS) is a self-rating scale for the assessment of perceived empowerment at the dimensions daily living and occupation, social relationships, participation in the treatment process, sense of control and hopefulness [67,68]. Originally developed for patients with affective and schizophrenia spectrum disorders, the EPAS was found to show good psychometric properties also in use with patients with other diagnoses [67]. For this investigation the EPAS total score was used.

The brief version of the “World Health Organization Quality of Life” instrument (WHOQOL-BREF) is a 24 item short version of the WHOQOL-100 which includes 100 items. The WHOQOL-BREF is a self-rating instrument assessing subjective quality of life at four dimensions physical health, psychological well-being, social relationships and environment and a global score including two items on perceived overall quality of life and overall satisfaction with health [69,70]. For this analysis the WHOQOL-BREF global quality of life score was used.

The “Perceived Impact of COVID-19” scale (PICOV19) was developed for the purpose of assessing how our study participants perceived the impact of the pandemic on 9 dimensions: 1. Physical well-being; 2. cognitive functioning; 3. emotional wellbeing; 4. partnership; 5. social contacts; 6. financial situation; 7. housing situation; 8. mobility; 9. future expectations. For each of these dimensions participants were asked how the COVID-19 pandemic had affected it. The generation of the PICOV19 items was based on the assumption that the effects of lockdown measures implemented by the public health authorities to reduce infection risk could be perceived positively or negatively by patients with SMI. While negative effects could be expected due to limitations of usual activities and restrictions of individual freedom, positive effects could be expected by reducing daily hassles and the need for social interaction or having more time for family activities. Therefore, the answering categories for the items of the PICOV19 scale were 1 = very negative, 2 = negative, 3 = neither positive nor negative, 4 = positive, 5 = very positive. For the purpose of data analyses all items were reversely coded into negative direction. In addition to the analyses of the single items we generated a PICOV19 sum scores of the 9 items.

Statistical analyses

For descriptive information on sample characteristics we computed means and standard deviations or absolute and relative frequencies. The internal consistency of the PICOV-19 was tested by means of Cronbach’s alpha. We also estimated means and 95% confidence intervals of the baseline and six-months follow-up (FU) assessments of the 9 dimensions and the total sum score (PICOV19) of the perceived impact of the COVID-19 pandemic on daily life.

We computed mixed effects regression models for each of the 9 dimensions of the negative effects due to the COVID-19 pandemic and for the PICOV19 total scale. We included the following independent variables: SARS-CoV-2 infection status (yes vs. no); male gender (yes vs. no), age, partnership status (having a partner vs not having a partner); education (A-levels vs lower); monthly family income (6 categories in steps of 500 €); employment status (employed vs not employed); self-reported main ICD-10 diagnosis (dummy variables using F3 as reference category); EPAS total score; HoNOS total score; time (six-months FU vs. baseline assessment) and two interaction terms for time*EPAS and time*HoNOS.

In order to analyze the impact of perceived negative effects of the COVID-19 pandemic on Quality of Life and the role of empowerment and illness severity in this process we generated a path model linking the baseline measures of empowerment (EPAS total score) and impairment due to mental disorder (HoNOS total score) with the PICOV19 at baseline and six-months FU and with global quality of life (WHOQOL-BREF) at six-months FU. All path coefficients were controlled for sex, age, education, income, partnership status, employment status, current smoking status, body mass index (BMI) main ICD-10 diagnosis and if the patients reported a SARS-CoV II infection between baseline and six-months FU. Missing values were handled by using the full information maximum likelihood (FIML) estimator [71,72]. Overall model fit of the path model will be indicated by a non-significant Chi2 test, a Root Mean Square Error of Approximation (RMSEA) < = 0.05; a Comparative Fit Index (CFI) and a Tucker-Lewis Index (TLI) both > 0.95 and a Standardized Root Mean Square Residual (SRMR) < = 0.05 [73].

Results

As shown in Table 1, 931 persons were included in the analyses at baseline and 768 could be included at six-months FU. The comparison of sample characteristics does not indicate any selection bias in those who were lost at follow-up.

thumbnail
Download:
Table 1. Sample characteristics.

https://doi.org/10.1371/journal.pone.0276123.t001

Fig 1 shows the raw means and the 95% confidence intervals of the PICOV19 items and the PICOV19 summary scale at baseline (t0) between June 2020 and December 2020 and six-months FU (t1) between December 2020 and June 2021. At baseline, the housing situation was reported to be the least impacted with a mean of 3.09 (95% CI = 3.05–3.12), followed by partnership with a mean of 3.25 (95% CI = 3.20–3.30). The highest impact was reported for emotional well-being with a mean of 3.96 (95% CI = 3.92–4.01) as well as social contacts with a mean of 3.90 (95% CI = 3.85–3.96). The comparison of the raw means between t0 and t1 assessments indicate increased perceptions of negative effects of the COVID-19 pandemic on physical well-being (ß = 0.086; 95% CI = 0.024–0.148; p = 0.007) and on social contacts (ß = 0.081; 95% CI = 0.019–0.143; p = 0.010). All other differences were not significant as p < 0.05.

thumbnail
Download:
Fig 1. Means and 95% confidence intervals of the PICOV19 items and the total score at baseline (blue) and six months follow-up (red).

The scale is reversely coded indicating: 1 = very positive effects; 2 = positive effects; 3 = neither positive nor negative effects, 4 = negative effects, 5 = very negative effects.

https://doi.org/10.1371/journal.pone.0276123.g001

As indicated by final mixed effects regression models (see Table 2), the intensity of negative effects of the COVID-19 pandemic was perceived higher in participants who were positively tested of having a SARS-CoV-2 infection for the areas of physical well-being (b = 0.33; p <0.001) and mobility (ß = 0.20; p = 0.042). With increasing age participants perceived more negative effects concerning social contacts (ß = 0.0; p = 0.011), mobility (ß = 0.01; p = 0.000), and future (ß = 0.00; p = 0.004). Participants with a higher education perceived more negative effects than those with lower education with regard to cognitive capability (ß = 0.08; p = 0.027), social contacts (ß = 0.11; p = 0.023), and mobility (ß = 0.18; p = 0.000). Participants with higher income perceived more negative effects regarding emotional well-being (ß = 0.04; p = 0.009) but less negative effects regarding their financial situation (ß = -0.04; p = 0.009). Employed participants perceived more negative effects of the COVID-19 pandemic concerning their housing situation (ß = 0.06; p = 0.049) but less negative effects concerning their future than those who were not employed (ß = -0.10; p = 0.015).

thumbnail
Download:
Table 2. Mixed effects regression models for the perceived negative effects of the COVID-19 pandemic (standardized regression coefficients and p-values).

https://doi.org/10.1371/journal.pone.0276123.t002

Compared to participants with a diagnosis of an affective disorder, those with a schizophrenia spectrum disorder perceived less negative effects of the COVID-19 pandemic on their emotional well-being (ß = -0.30; p = 0.000), partnership (ß = -0.22; p = 0.004), social contacts (ß = -0.30; p = 0.000), their financial situation (ß = -0.26; p = 0.001), their mobility (ß = -0.18; p = 0.018) and their future (ß = -0.23; p = 0.003). Participants with a personality disorder perceived less severe negative effects than those with an affective disorder regarding their emotional well-being (ß = -0.31; p = 0.001).

Between baseline assessment and six-months FU, participants perceived increasing negative effects of the COVID-19 pandemic regarding their physical well-being (ß = 0.76; p = 0.008), their emotional well-being (ß = 0.76; p = 0.006), and their future (ß = 0.63; p = 0.027).

With increasing PE, participants perceived less negative effects of the COVID-19 pandemic regarding cognitive functioning (ß = -0.21; p = 0.000), emotional well-being (ß = -0.26; p < = 0.000), their partnership (ß = -0.11; p = 0.042), their social contacts (ß = -0.19; p = 0.001), their housing situation (ß = -0.09; p = 0.042) and their future (ß = -0.28; p = 0.000).

With increasing functional impairment due to mental illness, participants perceived increasing negative effects of the COVID-19 pandemic regarding their physical well-being (ß = 0.02; p = 0.000), emotional well-being (ß = 0.02; p = 0.003), housing situation (ß = 0.01; p = 0.029) and their future (ß = 0.01; p = 0.010).

As indicated by the coefficient for the time*EPAS interaction term, increasing PE was related to a decreasing growth of perceived negative effects of the COVID-19 pandemic between baseline assessment and six-months FU, concerning physical well-being (ß = -0.21; p = 0.004), cognitive functioning (ß = -0.13; p = 0.050), emotional well-being (ß = -0.26; p = 0.000), partnership (ß = -0.11; p = 0.042), social contacts (ß = -0.19; p = 0.001), housing situation (ß = -0.09; p = 0.042), and future (ß = -0.28; p = 0.000). The coefficients for the time*HoNOS interaction term indicated no significant moderation effect due to participants’ level of functional impairment.

Cronbach’s alpha for the PICOV19 summary scale was estimated 0.75 at baseline and 0.77 at six-months FU indicating a sufficient reliability.

The results of the mixed effects regression model for the PICOV19 total score (see Table 3) indicate that having a higher education was associated with the perception of more negative effects in comparison to having a lower education (ß = 0.08; p = 0.001). Compared to participants with a diagnosis of an affective disorder, those with a diagnosis of a schizophrenia spectrum disorder (ß = -0.20; p = 0.000) and those with a diagnosis of a personality disorder (ß = -0.11; p = 0.026) experienced less negative effects of the COVID-19 pandemic. As indicated by the coefficients for the main effects of the HoNOS and the EPAS, baseline values of the PICOV19 total score increased with increasing level of functional impairment due to mental illness (ß = 0.01; p = 0.000), but decreased with increasing level of PE (ß = -0.17; p = 0.000). While the overall perception of negative effects increased between baseline assessment and six-months FU (ß = 0.42; p = 0.002), the increase was significantly lowered by the level of PE measured by the EPAS (ß = -0.11; p = 0.000).

thumbnail
Download:
Table 3. Mixed effects regression model for the PICOV19 total score (standardized regression coefficients and p values).

https://doi.org/10.1371/journal.pone.0276123.t003

As indicated by the standardized path coefficients presented in Fig 2 the functional impairment due to mental illness, measured by the HoNOS total score at baseline, was related to an increased negative impact of the pandemic six-months FU at baseline (ß = 0.157; p = 0.000) and at six-months FU (ß = 0.078; p = 0.038) and to decreased quality of life at six-months FU (ß = -0.247; p = 0.000) < 0.001). Baseline empowerment was associated with a decreased negative impact of the pandemic at baseline (ß = -0.194; p = 0.000) and at six-months FU (ß = -0.175; p = 0.000) and with increased quality of life at six-months FU (ß = 0.203; p = 0.000).

thumbnail
Download:
Fig 2. Standardized path coefficients (ß); controlled for SARS-CoV-2 infection in the past, sex, age, education, income, partnership status, employment status, current smoking status, BMI and main ICD-10 diagnosis.

* p < = 0.05, ** p< = 0.01, *** p < = 0.001.

https://doi.org/10.1371/journal.pone.0276123.g002

The decomposition of total direct and indirect effects revealed a total positive effect from empowerment at baseline to quality of life at a six-months FU (ß = 0.281; p = 0.000) consisting of a direct effect (ß 0.203; p = 0.000) and a total indirect effect (ß = 0.078; p = 0.000) which largely runs over the perception of a negative impact of the pandemic on the PICOV19 score six-months FU(ß = 0.059; p = 0.000) and over the combined effect of the PICOV19 score at baseline and at six-months FU(ß = -0.031; p = 0.000). The total effect of the HoNOS baseline score to quality of life at a -six-months FU(ß = 0.288; p = 0.000) consists of the direct effect (ß = - 0.247; p = 0.000) and a total indirect effect (ß = -0.042; p = 0.004) mainly running via the perception of a negative impact of the COVID-19 pandemic on the PICOV19 total score at baseline (ß = -0.026; p = 0.045) and over the combined effect of the negative impact of the pandemic at baseline and at six-months FU (ß = -0.025; p = 0.001).

As indicated by the R2 coefficients, the model explained 14% of the variance of the perceived negative impact of the COVID-19 pandemic measured by the PICOV19 score at baseline and 37.6% of the variance of the PICOV19 score at six-months FU and 36% of the variance of quality of life at six-months follow-up.

The overall model fit parameter reveals a very good model fit with a nonsignificant Chi2 2.567 (p = 0.2771), RMSEA of 0.018 (95% CI = 0.000–0.071) with a probability of 79% to be < = 0.05; CFI = 0.999, TLI = 0.975 and SRMR = 0.005.

Discussion

Overall, our study results confirm the hypothesis shared by many researchers that the negative consequences of the COVID-19 pandemic on people with mental disorders go far beyond the physical health impairments potentially caused by a SARS CoV-II infection [16,18,19,21–27]. We found direct effects of a SARS CoV-II infection only for perceived negative effects on physical well-being and on mobility. This leaves the question of what affects the perception of negative effects on the other dimensions of life. Against the expectations of several authors [17,19], compared to a diagnosis of depression, a diagnosis of schizophrenia was rather related to a lower perception of negative effects on six of the nine dimensions of daily living. However, the lower perception of negative effects due to the COVID-19 pandemic in patients with schizophrenia compared to other diagnosis groups was also reported in other studies [28,33,37,50]. An explanation for these counterintuitive results could be that the restrictions in public life following lockdown measures were associated with lower levels of social and environmental stress, while the limitations in face to face treatment contacts in many countries were substituted by digital media consultation [74–79]. Nevertheless, our results also indicate that perceived negative effects of the COVID-19 pandemic increase with increasing level of functional impairment due to mental disorders, at least on the dimensions of physical and emotional well-being, partnership, housing situation, and expectations for the future but also on the PICOV19 score. These results make it obvious that patients who are strongly affected by their mental illness also need the most intensive support in coping with the negative effects of the COVID-19 pandemic.

Our study results also suggest that PE, in the sense of a perceived control over key dimensions of life, represents an essential resource in people with SMI to cope with adversities of the COVID-19 pandemic. Increasing PE is associated with lower perception of negative effects of the COVID-19 pandemic on seven of the nine dimensions assessed with the PICOV19. Moreover, PE was associated with a reduced increase of perceived negative effects during the course of the pandemic over six months on the dimensions of physical and emotional well-being, cognitive functioning, social contacts, expectations for the future, and on the PICOV19 total score.

Limitations

Limitations result mainly from the fact that our study design was not developed to measure effects of the COVID-19 pandemic. As a consequence we do not have real baseline measures for the effects of the pandemic. In addition, the fact that the study sample includes only participants who were eligible for the enrollment in the GBV program, limits the representability of the results with regard to the population of patients with SMI.

Conclusions

Independent of their SARS-CoV II infection status patients with SMI had a high risk of experiencing negative consequences of the COVID-19 pandemic on their daily lives. Perception of negative consequences increased with severity of illness and decreased with the level of perceived empowerment (PE). Promotion of PE should be considered an important component of mental health care in this target group [63,67].

Acknowledgments

We acknowledge the support of the local service providers for community-based mental health care (GBV), specifically: Netzwerk integrierte Gesundheitsversorgung (NiG) Pinel gGmbH, Berlin; Medizinisch technischen Versorgungszentrum (MtVZ) Dresden GmbH, Dresden; Gesellschaft für psychische Gesundheit in Nordrhein-Westfalen (GpG NRW) gGmbH, Solingen; Ivita Rheinland-Pfalz und Saarland gGmbH, Koblenz; INTEGRE GmbH, Augsburg; and VICENTRO gGmbH, München. Moreover, we thank all of the local health service providers who have contributed to patient recruitment. Furthermore, deep appreciation goes to the statutory health insurance, which will contribute to successful project performance through diverse supportive actions.

References

  1. 1. Henssler J, Stock F, van Bohemen J et al. (2021) Mental health effects of infection containment strategies: quarantine and isolation-a systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience 271(2):223–234. pmid:33025099
  2. 2. Pfefferbaum B, North CS (2020) Mental Health and the Covid-19 Pandemic. N Engl J Med 383(6):510–512. pmid:32283003
  3. 3. Bäuerle A, Teufel M, Musche V et al. (2020) Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J Public Health (Oxf) 42(4):672–678. pmid:32657323
  4. 4. Winkler P, Formanek T, Mlada K et al. (2020) Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys. EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES 29:e173. pmid:32988427
  5. 5. Winkler P, Mohrova Z, Mlada K et al. (2021) Prevalence of current mental disorders before and during the second wave of COVID-19 pandemic: An analysis of repeated nationwide cross-sectional surveys. Journal of psychiatric research 139:167–171. pmid:34062293
  6. 6. Aknin LB, Neve J-E de, Dunn EWet al. (2022) Mental Health During the First Year of the COVID-19 Pandemic: A Review and Recommendations for Moving Forward. Perspect Psychol Sci:17456916211029964. pmid:35044275
  7. 7. Ettman CK, Abdalla SM, Cohen GH et al. (2020) Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Netw Open 3(9):e2019686. pmid:32876685
  8. 8. Richter D, Riedel-Heller S, Zürcher SJ (2021) Mental health problems in the general population during and after the first lockdown phase due to the SARS-Cov-2 pandemic: rapid review of multi-wave studies. EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES 30:e27. pmid:33685551
  9. 9. Röhr S, Reininghaus U, Riedel-Heller SG (2020) Mental wellbeing in the German old age population largely unaltered during COVID-19 lockdown: results of a representative survey. BMC Geriatr 20(1):489. pmid:33225912
  10. 10. Iasevoli F, Fornaro M, D’Urso G et al. (2021) Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy. Psychol Med 51(6):1054–1056. pmid:32423496
  11. 11. Aragona M, Barbato A, Cavani A et al. (2020) Negative impacts of COVID-19 lockdown on mental health service access and follow-up adherence for immigrants and individuals in socio-economic difficulties. Public Health 186:52–56. pmid:32771661
  12. 12. Asch DA, Buresh J, Allison KC et al. (2021) Trends in US Patients Receiving Care for Eating Disorders and Other Common Behavioral Health Conditions Before and During the COVID-19 Pandemic. JAMA Netw Open 4(11):e2134913. pmid:34783829
  13. 13. Killgore WDS, Taylor EC, Cloonan SA et al. (2020) Psychological resilience during the COVID-19 lockdown. Psychiatry Res 291:113216. pmid:32544705
  14. 14. Zabaniotou A (2020) A systemic approach to resilience and ecological sustainability during the COVID-19 pandemic: Human, societal, and ecological health as a system-wide emergent property in the Anthropocene. Glob Transit 2:116–126. pmid:32835203
  15. 15. Fegert JM, Schulze UME (2020) COVID-19 and its impact on child and adolescent psychiatry—a German and personal perspective. Ir. j. psychol. Med. 37(3):243–245. pmid:32404219
  16. 16. Adorjan K, Pogarell O, Pröbstl L et al. (2021) Auswirkungen der COVID-19-Pandemie auf die Versorgungssituation in psychiatrischen Kliniken in Deutschland (Impact of the COVID-19 pandemic on the care situation in psychiatric hospitals in Germany). Nervenarzt 92(6):562–570. pmid:34003321
  17. 17. Adorjan K, Haussmann R, Rauen K et al. (2021) Folgen der COVID-19-Pandemie für Menschen mit Schizophrenie, Demenz und Abhängigkeitserkrankungen (Consequences of the COVID-19 pandemic for people with schizophrenia, dementia and substance use disorders). Nervenarzt 92(6):571–578. pmid:33779773
  18. 18. Adorjan K, Koller G, Falkai P et al. (2020) Patienten mit psychischen Erkrankungen und einer SARS-CoV-2-Infektion. MMW Fortschr Med 162(S7):3–9. pmid:33289913
  19. 19. Kozloff N, Mulsant BH, Stergiopoulos V et al. (2020) The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders. Schizophr Bull 46(4):752–757. pmid:32343342
  20. 20. Melamed OC, Hahn MK, Agarwal SM et al. (2020) Physical health among people with serious mental illness in the face of COVID-19: Concerns and mitigation strategies. General Hospital Psychiatry 66:30–33. pmid:32645586
  21. 21. Fornaro M, Prisco M de, Billeci M et al. (2021) Implications of the COVID-19 pandemic for people with bipolar disorders: A scoping review. J Affect Disord 295:740–751. pmid:34517248
  22. 22. Dondé C, Pouchon A, Pelluet A et al. (2021) The Impact of Wearing a Face Mask on the Psychiatric Interview: a National Survey During the COVID-19 Pandemic. Psychiatr Q:1–8. pmid:34626317
  23. 23. Sheridan Rains L, Johnson S, Barnett P et al. (2021) Early impacts of the COVID-19 pandemic on mental health care and on people with mental health conditions: framework synthesis of international experiences and responses. Soc Psychiatry Psychiatr Epidemiol 56(1):13–24. pmid:32804258
  24. 24. Sánchez-Guarnido AJ, Hidalgo N, La Arenas de Cruz J et al. (2021) Analysis of the Consequences of the COVID-19 Pandemic on People with Severe Mental Disorders. Int J Environ Res Publ Health 18(16). pmid:34444298
  25. 25. Girolamo G de, Cerveri G, Clerici M et al. (2020) Mental Health in the Coronavirus Disease 2019 Emergency-The Italian Response. JAMA PSYCHIATRY 77(9):974–976. pmid:32352480
  26. 26. Busch AB, Huskamp HA, Raja P et al. (2022) Disruptions in Care for Medicare Beneficiaries With Severe Mental Illness During the COVID-19 Pandemic. JAMA Netw Open 5(1):e2145677. pmid:35089352
  27. 27. Newbronner E, Spanakis P, Wadman R et al. (2022) Exploring Access to Mental Health and Primary Care Services for People With Severe Mental Illness During the COVID-19 Restrictions. Front Psychiatr 12. pmid:35126210
  28. 28. Moran JK, Bretz J, Winkler J et al. (2021) The Differential Impact of Lockdown Measures Upon Migrant and Female Psychiatric Patients—A Cross-Sectional Survey in a Psychiatric Hospital in Berlin, Germany. Front Psychiatr 12:642784. pmid:34122174
  29. 29. Rek SV, Freeman D, Reinhard MA et al. (2021) Differential psychological response to the COVID-19 pandemic in psychiatric inpatients compared to a non-clinical population from Germany. European Archives of Psychiatry and Clinical Neuroscience:1–13. pmid:34268618
  30. 30. Heron P, Spanakis P, Crosland S et al. (2022) Loneliness among people with severe mental illness during the COVID-19 pandemic: Results from a linked UK population cohort study. PLoS ONE 17(1):e0262363. pmid:35025915
  31. 31. Favreau M, Hillert A, Osen B et al. (2021) Psychological consequences and differential impact of the COVID-19 pandemic in patients with mental disorders. Psychiatry Res 302:114045. pmid:34126461
  32. 32. Neelam K, Duddu V, Anyim N et al. (2021) Pandemics and pre-existing mental illness: A systematic review and meta-analysis. Brain, Behavior, & Immunity—Health 10:100177. pmid:33251527
  33. 33. Fleischmann E, Dalkner N, Fellendorf FT et al. (2021) Psychological impact of the COVID-19 pandemic on individuals with serious mental disorders: A systematic review of the literature. World J Psychiatry 11(12):1387–1406. pmid:35070784
  34. 34. Schützwohl M, Mergel E (2020) Teilhabemöglichkeit, Partizipation, Inklusion und psychisches Befinden im Zusammenhang mit Ausgangsbeschränkungen aufgrund SARS-CoV-2 (Social Participation, Inclusion and Mental Well-Being Following SARS-CoV-2 Related Restrictions on Going Out—A Follow-up Study from Germany). Psychiatr Prax 47(6):308–318. pmid:32688427
  35. 35. Mergel E, Schützwohl M (2021) COVID-19 und psychisches Befinden im zweiten Lockdown–Fortsetzung einer Verlaufsuntersuchung (COVID-19 and the Trajectory of Participation, Inclusion, and Psychological Well-Being Among Adults With and Without Mental Disorders—A Follow-up Study from Germany). Psychiatr Prax 48(5):265–268. pmid:34015848
  36. 36. Mergel E, Schützwohl M (2021) A longitudinal study on the COVID-19 pandemic and its divergent effects on social participation and mental health across different study groups with and without mental disorders. Soc Psychiatry Psychiatr Epidemiol 56(8):1459–1468. pmid:33569650
  37. 37. Belz M, Hessmann P, Vogelgsang J et al. (2021) Evolution of psychosocial burden and psychiatric symptoms in patients with psychiatric disorders during the Covid-19 pandemic. European Archives of Psychiatry and Clinical Neuroscience:1–12. pmid:33942148
  38. 38. Bartels C, Hessmann P, Schmidt U et al. (2021) Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders. European Archives of Psychiatry and Clinical Neuroscience. pmid:34825249
  39. 39. Caldiroli A, Capuzzi E, Tringali A et al. (2022) The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study. Psychiatry Res 307:114334.
  40. 40. Fasshauer JM, Bollmann A, Hohenstein S et al. (2021) Emergency hospital admissions for psychiatric disorders in a German-wide hospital network during the COVID-19 outbreak. Soc Psychiatry Psychiatr Epidemiol 56(8):1469–1475. pmid:33866383
  41. 41. Fasshauer JM, Bollmann A, Hohenstein S et al. (2021) Impact of COVID-19 pandemic on involuntary and urgent inpatient admissions for psychiatric disorders in a German-wide hospital network. Journal of psychiatric research 142:140–143. pmid:34352559
  42. 42. Hoyer C, Ebert A, Szabo K et al. (2021) Decreased utilization of mental health emergency service during the COVID-19 pandemic. European Archives of Psychiatry and Clinical Neuroscience 271(2):377–379. pmid:32519205
  43. 43. Seo JH, Kim SJ, Lee M et al. (2021) Impact of the COVID-19 pandemic on mental health service use among psychiatric outpatients in a tertiary hospital. J Affect Disord 290:279–283. pmid:34015622
  44. 44. Bollmann A, Hohenstein S, Pellissier V et al. (2021) Utilization of in- and outpatient hospital care in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network. PLoS ONE 16(3):e0249251. pmid:33765096
  45. 45. Gómez-Ramiro M, Fico G, Anmella G et al. (2021) Changing trends in psychiatric emergency service admissions during the COVID-19 outbreak: Report from a worldwide epicentre. J Affect Disord 282:26–32. pmid:33387743
  46. 46. O’Donoghue B, Collett H, Boyd S et al. (2021) The incidence and admission rate for first-episode psychosis in young people before and during the COVID-19 pandemic in Melbourne, Australia. Aust N Z J Psychiatry:48674211053578. pmid:34651504
  47. 47. Davies M, Hogarth L (2021) The effect of COVID-19 lockdown on psychiatric admissions: role of gender. BJPsych Open 7(4):e112. pmid:34099091
  48. 48. Jagadheesan K, Danivas V, Itrat Q et al. (2021) A 6-month study on the pattern of emergency department presentations for schizophrenia and other psychotic disorders during COVID-19 lockdown. Psychiatry Res 303:114081. pmid:34246006
  49. 49. Pinkham AE, Ackerman RA, Depp CA et al. (2020) A Longitudinal Investigation of the Effects of the COVID-19 Pandemic on the Mental Health of Individuals with Pre-existing Severe Mental Illnesses. Psychiatry Res 294:113493. pmid:33038789
  50. 50. Martinelli A, Ruggeri M (2020) The impact of COVID-19 on patients of Italian mental health supported accommodation services. Soc Psychiatry Psychiatr Epidemiol 55(10):1395–1396. pmid:32712677
  51. 51. Boevink W, Kroon H, Delespaul P et al. (2017) Empowerment according to Persons with Severe Mental Illness: Development of the Netherlands Empowerment List and Its Psychometric Properties. OJPsych 07(01):18–30.
  52. 52. Brohan E, Elgie R, Sartorius N et al. (2010) Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: the GAMIAN-Europe study. Schizophrenia Research 122(1–3):232–238. pmid:20347271
  53. 53. Corrigan PW (2002) Empowerment and serious mental illness: treatment partnerships and community opportunities. Psychiatric Quarterly 73:217–228. pmid:12143083
  54. 54. Finfgeld DL (2004) Empowerment of individuals with enduring mental health problems: results from concept analysis and qualitative investigations. Advanced Nursing Science 27:44–52.
  55. 55. Kilian R, Lindenbach I, Lobig U et al. (2003) Indicators of empowerment and disempowerment in the subjective evaluation of the psychiatric treatment process by persons with severe and persistent mental illness: a qualitative and quantitative analysis. Soc.Sci.Med. 57(6):1127–1142. pmid:12878111
  56. 56. Lanfredi M, Zoppei S, Ferrari C et al. (2015) Self-stigma as a mediator between social capital and empowerment among people with major depressive disorder in Europe: the ASPEN study. Eur. Psychiatry 30(1):58–64. pmid:25169444
  57. 57. Lundberg B, Hansson L, Wentz E et al. (2008) Stigma, discrimination, empowerment and social networks: a preliminary investigation of their influence on subjective quality of life in a Swedish sample. The International journal of social psychiatry 54(1):47–55. pmid:18309758
  58. 58. Zimmerman MA (1995) Psychological empowerment: issues and illustrations. American Journal of Community Psychology 23(5):581–599. pmid:8851341
  59. 59. Zimmerman MA (1990) Taking aim on empowerment research: on the distinction between individual and psychological conceptions. American Journal of Community Psychology 18(F):169–177.
  60. 60. Zimmerman MA (2013) Resiliency theory: a strengths-based approach to research and practice for adolescent health. Health Educ Behav 40(4):381–383. pmid:23863911
  61. 61. Tian X, Liu C, Zou G et al. (2015) Positive resources for combating job burnout among Chinese telephone operators: Resilience and psychological empowerment. Psychiatry Res 228(3):411–415. pmid:26165957
  62. 62. Fung K, Liu JJ, Vahabi M et al. (2021) Pandemic Acceptance and Commitment to Empowerment Response (PACER) Training: Protocol for the Development and Rapid-Response Deployment. JMIR Res Protoc 10(12):e33495. pmid:34726602
  63. 63. Mueller-Stierlin AS, Meixner F, Kohlmann A et al. (2020) Effectiveness and cost-effectiveness of a community-based mental health care programme (GBV) for people with severe mental illness in Germany: study protocol for a randomised controlled trial. Trials 21(1):598. pmid:32605585
  64. 64. Andreas S, Harfst T, Dirmaier J et al. (2007) A Psychometric evaluation of the German version of the ’Health of the Nation Outcome Scales, HoNOS-D’: on the feasibility and reliability of clinician-performed measurements of severity in patients with mental disorders. Psychopathology 40:116–125.
  65. 65. Wing JK, Lelliott P, Beevor AS et al. (2000) HoNOS update. Br J Psychiatry 176:392–395. pmid:10827890
  66. 66. Andreas S, Harfst T, Rabung S et al. (2010) The validity of the German version of the Health of the Nation Outcome Scales (HoNOS-D): a clinician-rating for the differential assessment of the severity of mental disorders. Int J Methods Psychiatr Res 19(1):50–62. pmid:20191659
  67. 67. Mueller-Stierlin AS, Helmbrecht MJ, Herder K et al. (2017) Does one size really fit all? The effectiveness of a non-diagnosis-specific integrated mental health care program in Germany in a prospective, parallel-group controlled multi-centre trial. BMC Psychiatry 17(1):283. pmid:28764729
  68. 68. Kilian R, Becker T, Schleuning G et al. (2012) Die Entwicklung eines standardisierten Verfahrens zur Messung von Empowerment im Prozess der sychiatrischen Behandlung von Patienten mit schweren psychischen Erkrankungen. Abschlussbericht. BMBF Förderkennz. 01GX0743, Ulm.
  69. 69. The WHOQOL Group (1998) Development of the world health organization WHOQOL-BREF quality of life assessment. Psychol Med 28:551–558.
  70. 70. (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine 28(3):551–558.
  71. 71. van Smeden M, Penning de Vries BBL, Nab L et al. (2021) Approaches to addressing missing values, measurement error, and confounding in epidemiologic studies. J Clin Epidemiol 131:89–100. pmid:33176189
  72. 72. Muthen LK, Muthen BO (2017) Mplus 8: Unser’s Guide. Statistical analysis with latent variables, Eighth edition. Muthen & Muthen, Los Angeles.
  73. 73. Muthen BO (2004) Mplus technical appendices. Muthn & Muthn, Los Angeles CA.
  74. 74. Lohmiller J, Schäffeler N, Zipfel S et al. (2021) Higher Acceptance of Videotelephonic Counseling Formats in Psychosomatic Medicine in Times of the COVID-19 Pandemic. Front Psychiatr 12:747648. pmid:34777051
  75. 75. Savilahti EM, Lintula S, Häkkinen L et al. (2021) Adolescent psychiatric outpatient care rapidly switched to remote visits during the COVID-19 pandemic. BMC Psychiatry 21(1):586. pmid:34800997
  76. 76. Looi JC, Allison S, Bastiampillai T et al. (2021) Telepsychiatry and face-to-face psychiatric consultations during the first year of the COVID-19 pandemic in Australia: patients being heard and seen. Australas Psychiatry:10398562211046301. pmid:34809483
  77. 77. Chow MW, Noorthoorn EO, Wierdsma AI et al. (2021) Impact of the first COVID-19 outbreak on mental health service utilisation at a Dutch mental health centre: retrospective observational study. BJPsych Open 7(6):e213. pmid:34784994
  78. 78. Scholl J, Kohls E, Görges F et al. (2021) Acceptability and Feasibility of the Transfer of Face-to-Face Group Therapy to Online Group Chats in a Psychiatric Outpatient Setting During the COVID-19 Pandemic: Longitudinal Observational Study. JMIR Form Res 5(7):e27865. pmid:34161252
  79. 79. Appleton R, Williams J, Vera San Juan N et al. (2021) Implementation, adoption and perceptions of telemental health during the COVID-19 pandemic: a systematic review. J Med Internet Res. pmid:34709179